高级检索
当前位置: 首页 > 详情页

Cognitive behavior therapy for insomnia in cancer patients: a systematic review and network meta-analysis

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Lanzhou Univ, Sch Basic Med Sci, Evidence Based Med Ctr, Lanzhou 730000, Peoples R China [2]McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada [3]Univ Cambridge, Sch Clin Med, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England [4]Lanzhou Univ, Sch Nursing, Evidence Based Nursing Ctr, Lanzhou, Peoples R China [5]Peking Univ, Sch Nursing, Beijing, Peoples R China [6]Mianyang Hosp Tradit Chinese Med, Mianyang, Sichuan, Peoples R China [7]Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing, Peoples R China [8]Capital Med Univ, Beijing Friendship Hosp, Natl Clin Res Ctr Digest Dis, Beijing, Peoples R China [9]Univ Hong Kong, Shenzhen Hosp, Shenzhen, Peoples R China [10]Tianjin Univ Tradit Chinese Med, Evidence Based Med Ctr, Tianjin, Peoples R China [11]Cent South Univ, Dept Breast Canc, Xiangya Hosp 2, Changsha, Hunan, Peoples R China [12]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Natl Canc Ctr, Beijing, Peoples R China [13]Lanzhou Univ, Clin Med Coll 1, Lanzhou, Peoples R China [14]Indiana Univ Sch Med, Melvin & Bren Simon Comprehens Canc Ctr, Dept Biochem, Indianapolis, IN 46202 USA [15]Indiana Univ Sch Med, Melvin & Bren Simon Comprehens Canc Ctr, Dept Mol Biol, Indianapolis, IN 46202 USA [16]Gansu Univ Chinese Med, Sch Publ Hlth, Epidemiol & Evidence Based Med, Lanzhou, Peoples R China [17]Lanzhou Univ, Evidence Based Social Sci Res Ctr, Sch Publ Hlth, Lanzhou 730000, Peoples R China [18]Key Lab Evidence Based Med & Knowledge Translat G, Lanzhou, Peoples R China
出处:
ISSN:

关键词: Cancer CBT-I delivery format efficacy insomnia network meta-analysis

摘要:
Objective The aim of this study was to examine the most effective delivery format of cognitive behavioral therapy for insomnia (CBT-I) on insomnia in cancer patients. Methods We searched five databases up to February 2021 for randomized clinical trials that compared CBT-I with inactive or active controls for insomnia in cancer patients. Outcomes were insomnia severity, sleep efficiency, sleep onset latency (SOL), wake after sleep onset (WASO), and total sleep time (TST). Pairwise meta-analyses and frequentist network meta-analyses with the random-effects model were applied for data analyses. Results Sixteen unique trials including 1523 participants met inclusion criteria. Compared with inactive control, CBT-I could significantly reduce insomnia severity (mean differences [MD] = -4.98 points, 95% confidence interval [CI]: -5.82 to -4.14), SOL (MD = -12.29 min, 95%CI: -16.48 to -8.09), and WASO (MD = -16.58 min, 95%CI: -22.00 to -11.15), while increasing sleep efficiency (MD = 7.62%, 95%CI: 5.82% to 9.41%) at postintervention. Compared with active control, CBT-I could significantly reduce insomnia severity (MD = -2.75 points, 95%CI: -4.28 to -1.21), SOL (MD = -13.56 min, 95%CI: -18.93 to -8.18), and WASO (MD = -6.99 min, 95%CI: -11.65 to -2.32) at postintervention. These effects diminished in short-term follow-up and almost disappeared in long-term follow-up. Most of the results were rated as "moderate" to "low" certainty of evidence. Network meta-analysis showed that group CBT-I had an increase in sleep efficiency of 10.61%, an increase in TST of 21.98 min, a reduction in SOL of 14.65 min, and a reduction in WASO of 24.30 min, compared with inactive control at postintervention, with effects sustained at short-term follow-up. Conclusions CBT-I is effective for the management of insomnia in cancer patients postintervention, with diminished effects in short-term follow-up. Group CBT-I is the preferred choice based on postintervention and short-term effects. The low quality of evidence and limited sample size demonstrate the need for robust evidence from high-quality, large-scale trials providing long-term follow-up data.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 2 区 医学
小类 | 2 区 医学:内科
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 医学:内科
JCR分区:
出版当年[2020]版:
最新[2023]版:
Q1 MEDICINE, GENERAL & INTERNAL

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2020版] 出版当年五年平均[2016-2020] 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者单位: [1]Lanzhou Univ, Sch Basic Med Sci, Evidence Based Med Ctr, Lanzhou 730000, Peoples R China
通讯作者:
通讯机构: [1]Lanzhou Univ, Sch Basic Med Sci, Evidence Based Med Ctr, Lanzhou 730000, Peoples R China [17]Lanzhou Univ, Evidence Based Social Sci Res Ctr, Sch Publ Hlth, Lanzhou 730000, Peoples R China [18]Key Lab Evidence Based Med & Knowledge Translat G, Lanzhou, Peoples R China [*1]The Evidence-Based Medicine Centre, School of Basic Medical Sciences,Lanzhou University, Lanzhou 730000, China. [*2]The Evidence-Based Social Science Research Center, School of Public Health,Lanzhou University, Lanzhou 730000, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)